FR2388563A1 - Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires - Google Patents

Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Info

Publication number
FR2388563A1
FR2388563A1 FR7713009A FR7713009A FR2388563A1 FR 2388563 A1 FR2388563 A1 FR 2388563A1 FR 7713009 A FR7713009 A FR 7713009A FR 7713009 A FR7713009 A FR 7713009A FR 2388563 A1 FR2388563 A1 FR 2388563A1
Authority
FR
France
Prior art keywords
capsular polysaccharides
advanced
vaccines containing
vaccine
acellular vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713009A
Other languages
English (en)
Other versions
FR2388563B1 (fr
Inventor
Lucien Dussourd D Hinterland
Anne-Marie Pinel
Gerard Normier
Jacques Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7713009A priority Critical patent/FR2388563A1/fr
Priority to BE187182A priority patent/BE866464A/fr
Priority to ES469225A priority patent/ES469225A1/es
Priority to GB16933/78A priority patent/GB1603340A/en
Priority to CA302,203A priority patent/CA1103155A/fr
Priority to CH469078A priority patent/CH630806A5/fr
Priority to DE19782818922 priority patent/DE2818922A1/de
Priority to IT49126/78A priority patent/IT1156717B/it
Priority to NL7804660A priority patent/NL7804660A/xx
Priority to JP5262378A priority patent/JPS53136516A/ja
Publication of FR2388563A1 publication Critical patent/FR2388563A1/fr
Application granted granted Critical
Publication of FR2388563B1 publication Critical patent/FR2388563B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne un procédé de préparation de vaccins perfectionnés. Il s'agit d'un procédé destiné à potentialiser l'action des vaccins contenant à titre de principe vaccinal des ARN ou des ribosomes d'au moins une souche bactérienne à capsules polysaccharidiques, dans lequel on ajoute à ce vaccin les polysaccharides capsulaires extraits d'au moins une desdites souches bactériennes à capsules polysaccharidiques. Le procédé est utile notamment pour la préparation de vaccins pour la prévention des maladies respiratoires.
FR7713009A 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires Granted FR2388563A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
ES469225A ES469225A1 (es) 1977-04-29 1978-04-27 Procedimiento para potenciar la accion de las vacunas.
BE187182A BE866464A (fr) 1977-04-29 1978-04-27 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires.
CA302,203A CA1103155A (fr) 1977-04-29 1978-04-28 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
GB16933/78A GB1603340A (en) 1977-04-29 1978-04-28 Potentiated acellular vaccines
CH469078A CH630806A5 (en) 1977-04-29 1978-04-28 Method for preparing improved vaccines
DE19782818922 DE2818922A1 (de) 1977-04-29 1978-04-28 Verbesserte impfstoffe mit gehalt an kapselpolysacchariden
IT49126/78A IT1156717B (it) 1977-04-29 1978-04-28 Procedimento per ottenere vaccini acellulari potenziati
NL7804660A NL7804660A (nl) 1977-04-29 1978-04-28 Verbeterde vaccins.
JP5262378A JPS53136516A (en) 1977-04-29 1978-05-01 Cell extracted vaccine having polysacchride capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713009A FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Publications (2)

Publication Number Publication Date
FR2388563A1 true FR2388563A1 (fr) 1978-11-24
FR2388563B1 FR2388563B1 (fr) 1981-01-09

Family

ID=9190107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713009A Granted FR2388563A1 (fr) 1977-04-29 1977-04-29 Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Country Status (10)

Country Link
JP (1) JPS53136516A (fr)
BE (1) BE866464A (fr)
CA (1) CA1103155A (fr)
CH (1) CH630806A5 (fr)
DE (1) DE2818922A1 (fr)
ES (1) ES469225A1 (fr)
FR (1) FR2388563A1 (fr)
GB (1) GB1603340A (fr)
IT (1) IT1156717B (fr)
NL (1) NL7804660A (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024493A2 (fr) * 1979-08-08 1981-03-11 American Cyanamid Company Vaccin pneumocoqual multivalent
EP0030166A1 (fr) * 1979-09-24 1981-06-10 Merck & Co. Inc. Composition de vaccin pour la prévention des caries dentaires
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0041897A2 (fr) * 1980-06-09 1981-12-16 The President And Fellows Of Harvard College Antigène de polysaccharide de streptocoque et vaccins
FR2495939A1 (fr) * 1980-12-11 1982-06-18 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
EP0072513A2 (fr) * 1981-08-14 1983-02-23 Smithkline Biologicals S.A. Procédé de préparation de polysaccharides bactériens capsulaires antigéniques purifiés, produits obtenus et leur utilisation
WO1990011087A1 (fr) * 1989-03-23 1990-10-04 Medical Research International Limited Methode de preparation de vaccins
FR2703252A1 (fr) * 1993-03-31 1994-10-07 Torossian Fernand Narbey Complexe immunomodulateur anti SIDA.
WO2000054728A2 (fr) * 1999-03-17 2000-09-21 Pierre Fabre Sante Utilisation d'une composition bacterienne pour le traitement des maladies parodontales

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (fr) * 1977-11-28 1981-12-29 Dennis J. Carlo Vaccin contre les pneumocoques
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
JPH0651347U (ja) * 1992-12-21 1994-07-12 有限会社河上建築事務所 軒樋の枯葉止め
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
PT897427E (pt) * 1996-02-14 2005-01-31 Merck & Co Inc Processo de precipitacao de polissacarideos

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024493A3 (en) * 1979-08-08 1981-10-21 American Cyanamid Company Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
EP0024493A2 (fr) * 1979-08-08 1981-03-11 American Cyanamid Company Vaccin pneumocoqual multivalent
EP0030166A1 (fr) * 1979-09-24 1981-06-10 Merck & Co. Inc. Composition de vaccin pour la prévention des caries dentaires
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
EP0031285A3 (en) * 1979-12-21 1981-07-15 Pierre Fabre S.A. Immuno-stimulating preparations based on ribosomal rna and process for the preparation of the rna
WO1984000688A1 (fr) * 1979-12-21 1984-03-01 D Hinterland Lucien Dussourd Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
EP0035429B1 (fr) * 1980-02-20 1985-06-12 Pierre Fabre S.A. Complexe vaccinal contenant un antigène spécifique et vaccin le contenant
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0041897A2 (fr) * 1980-06-09 1981-12-16 The President And Fellows Of Harvard College Antigène de polysaccharide de streptocoque et vaccins
EP0041897A3 (en) * 1980-06-09 1982-07-14 President And Fellows Of Harvard College Polysaccharide antigen from streptococcus and vaccine containing the same
FR2495939A1 (fr) * 1980-12-11 1982-06-18 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
WO1982001995A1 (fr) * 1980-12-11 1982-06-24 Merieux Inst Procede de purification de polyosydes de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
EP0072513A2 (fr) * 1981-08-14 1983-02-23 Smithkline Biologicals S.A. Procédé de préparation de polysaccharides bactériens capsulaires antigéniques purifiés, produits obtenus et leur utilisation
EP0072513A3 (en) * 1981-08-14 1986-02-19 Smith Kline - Rit Societe Anonyme Dite: Process for the preparation of purified bacterial capsular antigenic polysaccharides, the obtained products and their use
WO1990011087A1 (fr) * 1989-03-23 1990-10-04 Medical Research International Limited Methode de preparation de vaccins
GB2248187A (en) * 1989-03-23 1992-04-01 Medical Research Int Method of preparing vaccines
GB2248187B (en) * 1989-03-23 1993-04-28 Medical Research Int Method of preparing vaccines
FR2703252A1 (fr) * 1993-03-31 1994-10-07 Torossian Fernand Narbey Complexe immunomodulateur anti SIDA.
WO1994022462A1 (fr) * 1993-03-31 1994-10-13 Fernand Narbey Torossian Complexe immunomodulateur anti-sida
US6503512B1 (en) 1993-03-31 2003-01-07 Fernand Narbey Torossian Anti-AIDS immunomodulator complex
WO2000054728A2 (fr) * 1999-03-17 2000-09-21 Pierre Fabre Sante Utilisation d'une composition bacterienne pour le traitement des maladies parodontales
FR2790961A1 (fr) * 1999-03-17 2000-09-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales
WO2000054728A3 (fr) * 1999-03-17 2000-11-16 Fabre Pierre Sante Utilisation d'une composition bacterienne pour le traitement des maladies parodontales

Also Published As

Publication number Publication date
ES469225A1 (es) 1978-11-16
JPS53136516A (en) 1978-11-29
DE2818922A1 (de) 1978-11-09
IT7849126A0 (it) 1978-04-28
BE866464A (fr) 1978-10-27
IT1156717B (it) 1987-02-04
CA1103155A (fr) 1981-06-16
GB1603340A (en) 1981-11-25
FR2388563B1 (fr) 1981-01-09
CH630806A5 (en) 1982-07-15
NL7804660A (nl) 1978-10-31

Similar Documents

Publication Publication Date Title
FR2388563A1 (fr) Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
RU94045898A (ru) Вакцинная композиция, способ стимулирования иммунной системы
FR2603107B1 (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus hiv et procedes de production de ces anticorps et de diagnostic de la presence de ce virus
IL86268A0 (en) Viral glycoprotein subunit vaccine
HUP9900061A1 (hu) Alumínium-foszfátra adszorbeált konjugált poliszacharid antigént tartalmazó vakcinakompozíciók
ES2151597T3 (es) Composiciones inmunogenicas de polisacaridos estreptococcicos del grupo a y procedimientos.
PT70610A (fr) Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient
FR2408352A1 (fr) Vaccin contre le cholera de la volaille
FR2399252A1 (fr) Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation
TR200001948T2 (tr) Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.
DE2961311D1 (en) Anti-influenza vaccine and process for its preparation
GR3002841T3 (en) 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines
ES412098A1 (es) Procedimiento para la produccion de inhibidores de sacara- sa.
ES2084576T3 (es) Vacuna contra la coccidiosis.
EP0317622A4 (fr) Prevention et traitement de maladies retrovirales.
CA1126155A (fr) Preparations immunogeniques faites a partir d'enveloppes cellulaires
Milton Choline acetylase in the gill plates of Mytilus edulis
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
NZ221066A (en) Trichokirin and derivatives
EP1073461A4 (fr) Chimeres virales comprenant des elements genetiques de caev et de vih-1
FR2385730A1 (fr) Medicament a base d'extrait de physarum
FR2385799A1 (fr) Vaccin a virus respiratoire syncytial
WO1988007367A3 (fr) Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants
FR2383970A1 (fr) Nouveaux steroides constitues par procede des spirooxazolidines steroidiennes, leur procede de preparation et medicaments les contenant

Legal Events

Date Code Title Description
TP Transmission of property